SNMP를 이용한 무선 AP 관리 시스템 구현 및 분석

김현우,이구연 강원대학교 정보통신연구소 2008 정보통신논문지 Vol.12 No.-

Traffic through wireless LANs increases dramatically due to the increase of notebook and PDA users. Therefore, network administrators need to optimize wireless networks by analyzing user groups, traffic patterns according to locations to avoid network bottlenecks and overloads. In this paper, we implement a wireless access point(AP) management system using SNMP which monitors traffic load of each AP and redistributes heavy traffic among APs for load balancing. The system also does packet format analysis and detect packets containing special text patterns. We measure and analyze the traffic load of the implemented system and show that the system is very useful when a wireless network having many APs has heavy traffic.

연결납세제도의 도입방안에 관한 연구

박정우,권현구 한국세무회계학회 2004 세무회계연구 Vol.15 No.-

연결납세제도는 법률적으로 독립되어 있지만 경제적으로는 일체성이 있는 기업집단을 하나의과세단위로 하는 세제이다. 1999년 공정거래법이 개정되어 지주회사의 설립 및 전환이 제한적으로 허용되면서부터 연결납세제도의 도입에 대한 주장이 제기되기 시작하였다. 기업 간의 세부담의 공평성 유지, 세제의 중립성 유지, 연결회계제도의 정착, 세제의 선진화를 위해서 도입이 절실하다는 것을 정부도 공감하였지만, 세수의 감소, 구조조정의 지연, 세무계산의 복잡화 및 조세행정비용의 증가를 들어 도입을 미루고 있다. 이에 본 연구는 정부의 연결납세제도 도입을 촉구하고자, 국내 조세환경에 맞는 연결납세제도의 기본적인 도입방안을 제시하는 데 그 목적이 있다. 이를 위하여 본 연구는 문헌을 통해서 연결납세제도의 이론적 배경을 검토하고, 주요국가의 연결납세제도에 대해 분석을 하였다. 그리고 11가지의 쟁점별로 나누어 우리나라의 조세실정에 맞는 연결납세제도의 도입방안을 제시하였다.

Quinolone 항균제의 임상약리

신상구,최강원,장우현 대한화학요법학회 1988 대한화학요법학회지 Vol.6 No.2

4-quinolone 항균제는 chloroquine 정제 과정에서 처음 발견되었으며, 1963년 nalidixic acid가 처음 임상적으로 사용되었고, 이후 많은 4-oxoquninolin-3-carboxylic acid derivative가 합성되어 임상적으로 이용되었다(1st generation compounds; nalidixic acid, cinoxacin, oxolinic acid). 그러나 이러한 제 1세대 quinolone 제제는 좁은 항균 spectrum을 지녔으며 invitro, in vivo에서 저항균주의 출현이 흔하고, 약동학적(pharmacokinetic) 성상에 있어 경구 투여후 혈장단백 결합율을 높고 체내소실이 매우 빠른 단점으로 전신 감염증 치료에 있어 MIC 이상의 혈장농도 유지가 어려운 점 등으로 단지 뇨로감염증의 치료에 국한 될 수밖에 없었다. 이후 1970년경에 제 1세대의 항균 spectrum을 넓힌 제 2세대 quinolone derivatives(pipemidic acid,flumequin)가 개발되었고, 이들의 특성은 Pseudo monas aeroginosa에 활성을 보이며 일부 enterobacteria 및 Mycoplasma, Chlamydae, Neisseria 및 Acinobacter에 제 1세대보다 더 강력한 항균력을 보인다. 그러나, 이들 제 2세대 역시 타 기존항균제에 비한 장점이 적고 이들의 약동학적 특성등으로 제 1세대와 마찬가지로 뇨로감염증 치료제로서의 이용가치 이상이 부여될 수 없었다. 그러나 제 2세대 중의 fluorinated quinolone인 flumequine이 보인 staphylococci 및 edterobacteria 등에 대한 항균력은 제 3세대의 fluorinated quin-olone derivatives의 장을 열게 하는데 중요 역할을 하게 되었고 근자에 개발된 제 3세대 quinolone 제제들은 전신감염증 치료제로서 적합한 약동학적 성상을 지녀 기존의 new-beta lactams제와 더불어 전신 감염증의 주요 치료약물로 대두될 단계에 이르렀다. 따라서, 본 종설에서는 이들 quinolone 제제중, 특히 제 3세대 quinolone 항균제들의 작용기전 및 항균력, 약동학적 특성 및 임상효과등에 대해 논하고자 하며, quinolone 제제에 대한 국내 연구결과를 소개하고자 한다.

유전자 알고리즘에 의한 모발로봇의 자세/위치 제어

한성현,이우송,김윤구,김홍래,조창제 한국공작기계학회 2006 한국공작기계학회 추계학술대회논문집 Vol.2006 No.-

This paper proposed trajectory tracking control of Mobile Robot. Trajectory tracking control scheme are Real coding Genetic-Algorithm and Back-propergation Algorithm. Control scheme ability experience is proposed by simulation.

조혈모세포이식 환자에서 침습성 진균 감염에 대한 Micafungin의 예방 효과 및 안전성

김시현,이동건,최수미,권재철,박선희,최정현,유진홍,이성은,조병식,김유진,이석,김희제,민창기,조석구,김동욱,이종욱,민우성,박종원 대한감염학회 2010 감염과 화학요법 Vol.42 No.3

Background: Micafungin, a potent inhibitor of 1,3-β-D-glucan synthase, is a novel antifungal agent of the echinocandin class. In vitro study showed that micafungin was effective against Aspergillus species as well as Candida species, but clinical data on the prophylactic efficacy against invasive fungal infections (IFIs) other than candidiasis are still lacking. Materials and Methods: We identified 60 consecutive adult hematopoietic stem cell transplantation (HSCT) recipients who received at least 3 doses of micafungin during neutropenic period. Micafungin was started as an alternative in patients who were intolerant or had adverse events (AEs) to primary prophylactic antifungal agents. We retrospectively reviewed the medical records and analyzed the efficacy and safety of micafungin for prophylaxis against IFIs. Results: The patients either had autologous (n=9) or allogeneic (n=51: 1 syngeneic, 24 sibling, 26 unrelated donor) HSCT. Itraconazole oral solution (n=58) was the most frequently used first line antifungal agent for prophylaxis and was administered for median 11 days. The most frequent cause of switch to micafungin was vomiting (n=42). The duration of neutropenia and micafungin administration was median 13 and 12 days, respectively. A successful outcome was achieved in 45 (75%) patients. Empirical antifungal therapy was initiated in 13 (22%) patients. There were 2 cases (3.3%) of breakthrough fungal infections which comprised a probable invasive pulmonary aspergillosis and a possible invasive fungal sinusitis. There was no case of invasive candidiasis. A total of 53 (88%) patients experienced at least one AE regardless of causality during micafungin administration. The most frequent AEs were hypokalemia, vomiting, diarrhea, and elevated serum aspartate aminotransferase or alanine aminotransferase. Among the aforementioned AEs, only 1 case of diarrhea could be classified as a probable relation with micafungin when causality was assessed. There was no AEs that caused discontinuation of micafungin. Conclusions: Micafungin seems to be a safe and effective agent for prophylaxis of IFIs including aspergillosis as well as candidiasis in HSCT recipients. However, further large, prospective, and randomized comparative studies are warranted for aspergillosis.

회수수에 당류계 안정화제를 처리한 시멘트 모르터의 특성

金虎林,우종완,한민철,류현기,한천구 대한건축학회 2004 대한건축학회 학술발표대회 논문집 - 계획계/구조계 Vol.24 No.1(구조계)

In this paper, fundamental properties of cement mortar using recycled water with stabilizing agent are discussed in order to investigate the applicability of recycled water. Stabilizing agent content, solid contents and open time are varied in this paper. For fresh mortar properties, highest fluidity with 0.15% of stabilizing agent was observed and air content was increased with an increase in stabilizing agent contents. Solid contents and open time of recycled water had nothing to do with fluidity and air content loss. Little difference in setting time was found with the presence of stabilizing agent and without, while it was accelerated with an increase in open time and solid content. For strength properties, the highest strength value was observed at 0.15% of stabilizing agent. An increase in solid contents resulted in an enhancement of strength, while strength decreased with an increase in open time and elapse of age. Drying shrinkage exhibited a reduction with an increase in stabilizing agent contents and open time. From the present paper, the combination of 0.15% of sacharic based stabilizing agent, 3% of solid content and 1day of open time is found to be an optimal condition to perform effectively.

대기오염 확산 해석을 위한 포항지역 기상장 연구 : 바람장 수치모의 Numerical Simulation of Wind Field

이화운,정우식,김현구,이순환 한국대기환경학회 2004 한국대기환경학회지 Vol.20 No.1

Sea/land circulation system is a representative mesoscale local circulation system in coastal area. In this study, wind fields around coastal area, Pohang, which is affected by this system was investigated and its detailed characteristic analysis was carried out. The following can be found out from the numerical simulation. Generally, at nighttime mountain winds prevail and land breeze toward the coastal area was well simulated. During daytime, valley wind and sea breeze was simulated in detail. Especially, as a result of analyzing the land breeze path, it could be found along the coastline as it flows out through low land coastal area. In order to investigate the accuracy of model results, wind speed, temperature and wind direction of continuous typical sea/land breeze occurrence day was compared with observation data. Analyzing the characteristics of local circulation system was very hard because of horizontally sparse observation data but from the above result, a numerical simulation using RAMS, which satisfies the spatial high resolution, will provide more accurate results.

좌심실 이완기 장애 평가에서 Atrioventricular Plane Displacement의 임상적 중요성

정연손,조구영,이태유,김근숙,최창순,류제헌,최민호,박우정,임종윤,이영 대한순환기학회 2003 Korean Circulation Journal Vol.33 No.12

Sodium Hydroxide용액에서 CR-39비적검출기의 부식조건 및 특성에 관한 연구

김동호,강동우,김현구 조선대학교 기초과학연구소 1988 自然科學硏究 Vol.11 No.1

A series of experiments was performed to find the optimum etching condition and the detection efficiency etc. of CR-39 track detector in order to get track detection. The CR-39 detectors It were irradiated with a 0.12 μC_i, Am-241 alpha source under a known geometrical arrangement. The detection efficiency for CR-39 detector used in this experiments was obtained about 80, 08±1.24% in the atmosphere and we concluded that 6.25N NaOH at 70℃ for 5.5hrs. represents the optimum etching condition for CR-39 detector. From the meaured bulk-etching rates at different temperatures, the activation energy for bulk-etching has been obtained. The activation energy, Q, was found to have a value of 0.73±0.O5eV for CR-39 detector.

녹동균 세포외막 단백질 백신 CFC-1-101의 안정성 및 면역원성 검토 : 임상 제 Ⅰ/Ⅱa상 시험

장인진,김익상,유경상,임동석,김형기,신상구,장우현,박완제,이나경,정상보,안동호,조양제,안보영,이윤하,김영지,남성우,김현수 대한감염학회 1998 감염 Vol.30 No.3

목적 : 제일제당에서는 녹농균의 세포외막 단밸질을 유효성분으로 하는 백신인 CFC-101을 개발하였으며, 동물시험에서 이 백신의 안전성과 유효성을 입증하였다. 본 연구에서는 이 녹농균 백신의 인체에 대한 안전성과 면역원성을 평가하는 동시에 인체 접종시의 최적 투여 용량을 결정하기 위하여 제 I/Ⅱa상 임상시험을 수행하였다. 방법 : 건강한 성인 남자를 피험자로 선별하여 각 용량군에 백신투여자 6명, 위약투여자 2명을 배정하였다. 백신 투여군은 0.25mg, 0.5mg 또는 1.0mg 용량의 녹농균 백신을 7일 간격으로 3회에 걸쳐 근육주사 하였으며, 위약 투여군에게는 세포외막 단백질을 제외한 동일한 성분을 투여하였다. 백신접종 후 국소적 또는 전신적인 반응의 발생여부를 관찰하고, 혈액시료를 체취하여 백신의 역가와 유효성을 검정하였다. 결과 : 녹농균 백신 CFC-101은 모든 접종자에서 양호한 내약성을 보였다. 또한 0.5mg 과 1.0mg 백신 투여군에서는 100%의 항체양전율을 나타내었다. 생성된 항체는 녹농균 세포외막단백질에 특이성을 보였고, 녹농균 감염에 대해 방어효능이 있었다. 결론 : 이와같은 결과로부터 이 녹농균 백신은 인체에 안전하게 투여할 수 있으며, 높은 항체 생성능으로 감염방어 효능을 보이고 0.5mg과 1.0mg이 최적용량인 것으로 판단되었다. Background : We developed a Pseudomonas aeruginosa outer membrane protein(OMP) vaccine CFC-101, and the prophylactic efficacy of which has been demonstrated in animal models. In order to evaluate the safety and immunogenicity of the P. aeruginosa vaccine, we carried out a phase I/Ⅱa clinical trial in healthy male volunteers. Methods : Groups of eight volunteers, including two placebo subjects, were vaccinated intramuscularly with three doses of 0.25, 0.5 or 1.0 mg of the vaccine at one week intervals. Sings of systemic and local reactions observed after vaccination were recorded for each vaccinee for 5 days. Physical examinations were performed on days 0, 1, 7, 8, 14, 15, 21, and 42, and clinical laboratory tests were done on days 0, 3, and 21. Blood samples for assay of serum antibody levels were obtained up to 42 days after the first vaccination. Results : The vaccine was generally well tolerated by all vaccinees, showing no significant side effects. In the three dosage groups, all vaccinees, except one receiving the 0.25 mg dose, showed significant elevation in serum IgG antibody titers against the vaccine proteins, indicating 100% seroconversion in 0.5 and 1.0 mg groups. The human antibodies induced by the vaccine were specific for P. aeruginosa OMPs, as confirmed by western blot analysis and immunoprecipitation assays. The capacity of the human antisera to enhance opsonophagocytic killing activity by polymorphonuclear leukocytes and to confer protection against P. aeruginosa infections indicates that the antibodies elicited by the vaccine have protective efficacy. Conclusion : We conclude that the P. aeruginosa OMP vaccine is safe and effective for human use and its optimal dose to be 0.5 or 1.0 mg.